ADMA Biologics reported FY 2024 revenue of $426.5 million, achieving significant increases in net income and adjusted EBITDA. ADMA Biologics, Inc. reported strong financial results for FY 2024, ...
Total revenues of US$122.6 million, a 55.3% increase year-over-year, highlight strong growth and market demand for UP Fintech's services. Net income attributable to ordinary shareholders rose to US$30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results